(Q43003938)

12 November 2017

title

Long-term outcome of mitomycin C- and 5-FU-based primary radiochemotherapy for esophageal cancer (English)

1 reference

12 November 2017

0 references

8

Claus Belka

1 reference

12 November 2017

Maria Wolf

1

1 reference

12 November 2017

Franz Zehentmayr

2

1 reference

12 November 2017

Maximilian Niyazi

3

1 reference

12 November 2017

Ute Ganswindt

4

1 reference

12 November 2017

Wolfgang Haimerl

5

1 reference

12 November 2017

Michael Schmidt

6

1 reference

12 November 2017

Dieter Hölzel

7

1 reference

12 November 2017

language of work or name

1 reference

24 June 2010

1 reference

Strahlentherapie und Onkologie

12 November 2017

published in

1 reference

12 November 2017

volume

186

1 reference

12 November 2017

issue

7

1 reference

12 November 2017

page(s)

374-381

1 reference

https://scigraph.springernature.com/pub.10.1007/s00066-010-2137-y

12 November 2017

exact match

0 references

cites work

Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: a randomized trial.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00066-010-2137-Y

Combined modality therapy for esophageal carcinoma: Preliminary results from a large Australasian multicenter study

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00066-010-2137-Y

Preoperative Chemoradiation in Locally Advanced Pancreatic Carcinoma: A Phase II Study

21 January 2018

1 reference

12 December 2020

Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiothera

1 reference

12 December 2020

Ten-year follow-up of esophageal cancer treated by radical radiation therapy: analysis of 869 patients

1 reference

12 December 2020

Chemoradiation: A Superior Alternative for the Primary Management of Esophageal Carcinoma

1 reference

12 December 2020

Irradiation, chemotherapy and surgery in esophageal cancer: a randomized clinical study. The first Scandinavian trial in esophageal cancer

1 reference

12 December 2020

Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study

1 reference

12 December 2020

Adenocarcinoma of the esophagus and cardia: a review of the disease and its treatment

1 reference

12 December 2020

Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus

1 reference

12 December 2020

Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group

1 reference

12 December 2020

Mitomycin C in advanced cervical cancer

1 reference

12 December 2020

[Effects of combination chemoradiotherapy with daily low-dose CDDP for esophageal cancer--results of a randomized trial]

1 reference

12 December 2020

Esophageal cancer. A prospective phase II study of concomitant-boost external-beam chemoradiation with a top-up endoluminal boost

1 reference

12 December 2020

Excess incidence of squamous cell esophageal cancer among US Black men: role of social class and other risk factors

1 reference

12 December 2020

Hyperfractionated, accelerated chemoradiation with concurrent mitomycin-C and cisplatin in locally advanced head and neck cancer, a phase I/II study

1 reference

12 December 2020

Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus

1 reference

12 December 2020

Long-term results of infusional 5-FU, mitomycin-C, and radiation as primary management of esophageal carcinoma

1 reference

12 December 2020

Multivariate analysis of treatment outcome in patients with esophageal carcinoma treated with definitive radiotherapy

1 reference

12 December 2020

Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus

1 reference

12 December 2020

INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy

1 reference

12 December 2020

Radio(chemo)therapy plus resection versus radio(chemo)therapy alone for the treatment of stage III esophageal cancer

1 reference

12 December 2020

Evidence-based radiation oncology: oesophagus

1 reference

12 December 2020

Autopsy findings in 111 cases of esophageal cancer

1 reference

12 December 2020

Downstaging of pancreatic carcinoma after neoadjuvant chemoradiation

1 reference

12 December 2020

Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection

1 reference

12 December 2020

Induction cisplatin-irinotecan followed by concurrent cisplatin-irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial

1 reference

12 December 2020

Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: evidence of a radiation and chemotherapy dose response

1 reference

12 December 2020

Radiation therapy and simultaneous chemotherapy for recurrent cervical carcinoma

1 reference

12 December 2020

A randomized trial comparing radiation therapy versus concomitant radiation therapy and chemotherapy in carcinoma of the thoracic esophagus

1 reference

12 December 2020

Significance of radiation therapy for adenocarcinomas of the esophagus, gastroesophageal junction and gastric cancer with special reference to the MAGIC trial

1 reference

12 December 2020

Histologic Tumor Type Is an Independent Prognostic Parameter in Esophageal Cancer: Lessons From More Than 1,000 Consecutive Resections at a Single Center in the Western World

1 reference

12 December 2020

Complete remission after neoadjuvant chemoradiation in a stage IV vulvar cancer patient

1 reference

12 December 2020

A randomized study of radiotherapy alone versus radiotherapy plus 5-fluorouracil and platinum in patients with inoperable, locally advanced squamous cancer of the esophagus

1 reference

12 December 2020

Late course accelerated hyperfractionation radiotherapy concomitant with cisplatin in patients with esophageal carcinoma

1 reference

12 December 2020

A controlled evaluation of combined radiation and bleomycin therapy for squamous cell carcinoma of the esophagus

1 reference

12 December 2020

Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study

1 reference

12 December 2020

Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer

1 reference

12 December 2020

Impact of VEGF and VEGF receptor 1 (FLT1) expression on the prognosis of stage III esophageal cancer patients after radiochemotherapy

1 reference

12 December 2020

Carcinoma of the esophagus. An autopsy study of 231 cases

1 reference

12 December 2020

10.1007/S00066-010-2137-Y

Identifiers

DOI

1 reference

12 November 2017

1 reference